You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 278 No. 5, August 6, 1997 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentaries
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Botulism Surveillance and Emergency Response

A Public Health Strategy for a Global Challenge

Roger L. Shapiro, MD; Charles Hatheway, PhD; John Becher, RPH; David L. Swerdlow, MD

JAMA. 1997;278(5):433-435.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Botulism is a neuroparalytic disease caused by a neurotoxin produced from an anaerobic spore-forming bacterium known as Clostridium botulinum.1 The lethal potency of this toxin has mandated intensive surveillance and control measures in the United States. Recent outbreaks of botulism have raised questions regarding the international supply and therapeutic use of botulism antitoxin, and reports that national governments2 and terrorist groups3 have stockpiled botulism toxin have increased levels of concern regarding global preparedness for an intentional episode of botulism poisoning. It is estimated that as little as 1 g of aerosolized botulism toxin has the potential to kill at least 1.5 million people, and modern techniques of aerosolization via tactical ballistic missiles or aeronautical spraying may be capable of disseminating up to 60% of this dosage to a target population.4

A description of the clinical features of aerosolized botulism toxin poisoning appears elsewhere in this issue. . . . [Full Text PDF of this Article]


Author Affiliations

From the Foodborne and Diarrheal Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Ga.


Footnotes

Corresponding author: Roger L. Shapiro, MD, Centers for Disease Control and Prevention, 1600 Clifton Rd, Mailstop A-38, Atlanta, GA 30333 (e-mail:rss9@cdc.gov).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.